AUG 7, 2026 · PHASE 2 TRIAL
Endocrine Response in Women With Invasive Lobular Breast Cancer
ClinicalTrials.gov
Phase 2 interventional study of neoadjuvant endocrine therapy in a specific breast cancer subtype using a surrogate endpoint (Ki67 proliferative index); recruitment completed but results not yet reported in this registry record.
Reported
Planned enrollment201
PhasePhase 2
Primary outcome measureChange in Log-transformed Ki67 Proliferativ…